Chargement en cours...
Use of Recombinant Factor VIIa in Patients With Warfarin-Associated Intracranial Hemorrhage
INTRODUCTION: Warfarin-associated intracranial hemorrhage (ICH) requires rapid normalization of clotting function. Current therapies are associated with significant complications and/or prolonged time to correction of coagulopathy. Recombinant factor VIIa (FVIIa) might allow faster and safer correct...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2005
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2535929/ https://ncbi.nlm.nih.gov/pubmed/16159073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1385/NCC:2:3:263 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|